Skip to main content

King Pharmaceuticals, Inc. Board Under Investors Investigation

  • If you are a current investor in King Pharmaceuticals, Inc. (NYSE:KG) shares, and/or have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

In response to the buyout offer by Pfizer to take over King Pharmaceuticals, Inc. at $14.25 an investigation on behalf of investors of King Pharmaceuticals, Inc. (NYSE:KG) over possible breaches of fiduciary duties in connection with the proposed takeover was announced. The investigation by a law firm concern whether King Pharmaceuticals and its Board of Directors breached their fiduc...



You must register (for free) or login to view the entire investigation.